Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Product sales, net $ 3,256 $ 3,865 $ 10,482 $ 11,821
Cost of goods sold 1,677 2,087 5,401 6,330
Gross profit 1,579 1,778 5,081 5,491
Operating expenses:        
Research and development 24 29 104 93
Selling, general and administrative 1,830 2,090 5,894 6,942
Benefit from reversal of accrued payroll taxes 0 0 (522) 0
Total operating expenses 1,854 2,119 5,476 7,035
Operating loss (275) (341) (395) (1,544)
Gain on extinguishment of debt 0 0 (38) 0
Interest expense, net 107 115 388 118
Loss before income taxes (382) (456) (745) (1,662)
Income tax expense 0 0 7 6
Net loss $ (382) $ (456) $ (752) $ (1,668)
Weighted average common shares outstanding, basic (in shares) 184,264 182,261 184,264 172,671
Weighted average common shares outstanding, diluted (in shares) 184,264 182,261 184,264 172,671
Net income (loss) per common share, basic (in USD per share) $ (0) $ (0) $ (0) $ (0.01)
Net income (loss) per common share, basic diluted (in USD per share) $ (0) $ (0) $ (0) $ (0.01)
Revenue, product and service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember